World: Press Releases

Welcome to the Investing News Network's press release section, where you can stay informed with past and present announcements from our clients. Explore the latest stock news from mining, technology and life science companies and gain an investing edge by staying up to date with today's press releases.
Filters
Clear All Filters
Filter✕

Date Range

Sector

Marvel Announces Final Shank3 Data: MB-204 Highly Effective at Reversing Autism Behaviours

pharmaceutical investing
BriaCell Therapeutics (BCT:CC)

BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026

biotech investing
BriaCell Therapeutics (BCT:CC)

BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026 

biotech investing
The Calmer Co (CCO:AU)

Appendix 4C Cashflow Statementand Quarterly Activities Report

psychedelics investing
BriaCell Therapeutics (BCT:CC)

BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer

biotech investing
BPH Energy (BPH:AU)

BPH Energy Limited September 2026 Quarter Operations Report

oil and gas investing
BPH Energy (BPH:AU)

Quarterly Activities/Appendix 4C Cash Flow Report

oil and gas investing
The Calmer Co (CCO:AU)

Coles Orders Fiji Kava® FZZR™ – First Flavoured Kava Product to Launch in Australia

psychedelics investing
BriaCell Therapeutics (BCT:CC)

BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting

pharmaceutical investing
BriaCell Therapeutics (BCT:CC)

BriaCell’s Bria-ABC Joins Roster of US-Enrolled Breast Cancer Trials

biotech investing
BriaCell Therapeutics (BCT:CC)

Data Safety Monitoring Board Recommends Continuing BriaCell's Phase 3 Metastatic Breast Cancer Study

pharmaceutical investing
BriaCell Therapeutics (BCT:CC)

BriaCell's Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center

pharmaceutical investing
BriaCell Therapeutics (BCT:CC)

BriaCell's Cell-Based ‘Melanoma’ Enters the Skin Cancer Vaccine Conversation

biotech investing
BriaCell Therapeutics (BCT:CC)

BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+

pharmaceutical investing

The Calmer Co. Secures Exclusive Global Distribution Agreement for Kava Extract Ingredients up to $25 million

psychedelics investing
Solvonis Therapeutics (None)

SVN-015 Advances into Further NIDA-Funded Studies Following Encouraging Initial Screening

BriaCell Therapeutics (BCT:CC)

BriaCell Receives FDA Clearance to Initiate Bria-PROS+ Clinical Study in Prostate Cancer

pharmaceutical investing
BPH Energy (BPH:AU)

BPH Energy Limited Quarterly Activities and Cash Flow Report

BriaCell Therapeutics (BCT:CC)

BriaCell Opens First Canadian Site - Sunnybrook - for Pivotal Phase 3 Trial in Metastatic Breast Cancer

pharmaceutical investing
BriaCell Therapeutics (BCT:CC)

BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT

pharmaceutical investing

Latest press releases News

More press releases News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES